Cancer Victims Uniting to Oppose Johnson & Johnson's Latest Bankruptcy Ploy
Justice requires people be compensated for expenses, suffering, and lost wages, say attorneys at Beasley Allen Law Firm
"Ovarian cancer and mesothelioma victims should and will be outraged if J&J attempts another dodge into bankruptcy," says
A proposed settlement announced by J&J as part of a second "Texas Two-Step" bankruptcy would seriously shortchange women who have incurred significant medical expenses, pain and suffering, and lost wages because of J&J's tainted and asbestos-laced talc products. Evidence uncovered during litigation revealed that the company knew that its products contained cancer-causing asbestos and concealed that information from consumers and government regulators. In response to public opinion, J&J eventually agreed to stop selling talc-based baby powder in
"This sham deal does not even pay for most victims' medical bills," says
In addition, the proposed deal does not replace wages lost while the victims are fighting cancer. The trauma and disabling nature of ovarian cancer and mesothelioma inevitably lead to job loss and lost wages. On average, a typical victim of talc loses more than
Click here to listen to some of these cancer victims discuss the litigation.
J&J's previous attempt to seek bankruptcy protection and block an estimated 50,000 claimants from seeking justice was rejected by the
A talc settlement out of bankruptcy would require approval by Chief Judge
About Beasley Allen Law Firm
Headquartered in
About
Arnold & Itkin is a trial law firm based in
Media Contact:
800-559-4534
[email protected]
View original content:https://www.prnewswire.com/news-releases/cancer-victims-uniting-to-oppose-johnson--johnsons-latest-bankruptcy-ploy-301790207.html
SOURCE Beasley Allen Law Firm
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Max Stock announces immediate report regarding a contract for the construction and lease of a logistics center in Southern Israel
- Govee Ushers in the Next Era of Smart Living with AI-Powered Lighting Innovation at IFA 2026
- Egetis Therapeutics to Participate in Upcoming Investor Conferences in September
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
BankruptcySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share